Published in Contemp Oncol (Pozn) on April 29, 2013
(18)F-FLT PET/CT in Patients with Gastric Carcinoma. Gastroenterol Res Pract (2013) 0.85
Undiagnosed Borrmann type IV gastric cancer despite repeated endoscopic biopsies and PET-CT examination: A case report. Oncol Lett (2016) 0.75
Evaluation of 64-Channel Contrast-Enhanced Multi-detector Row Computed Tomography for Preoperative N Staging in cT2-4 Gastric Carcinoma. World J Surg (2016) 0.75
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 16.97
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Clinical applications of PET in oncology. Radiology (2004) 3.44
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer (2001) 1.96
FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging (2002) 1.87
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer (2005) 1.70
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med (2005) 1.70
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med (2003) 1.57
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg (2009) 1.43
CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics (2006) 1.41
Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer (2006) 1.33
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med (2007) 1.21
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis. J Nucl Med (2007) 1.20
Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. Clin Positron Imaging (1998) 1.11
Surgical treatment of early gastric cancer. Jpn J Clin Oncol (1984) 1.04
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging (2008) 1.00
Positron Emission Tomography in oncology: present and future of PET and PET/CT. Crit Rev Oncol Hematol (2008) 0.85
The effect of chemotherapy against micrometastases and isolated tumor cells in lymph nodes: an in vivo study. In Vivo (2009) 0.80
Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol (2013) 1.50
Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int J Oncol (2006) 1.09
Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Genes Chromosomes Cancer (2006) 1.05
Evaluation of the effects of mammography screening program on cancer progression and implemented treatment in patients with breast cancer. Pol Przegl Chir (2013) 0.95
Cross-sectional study of the ossification center of the C1-S5 vertebral bodies. Surg Radiol Anat (2012) 0.93
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. Eur J Hum Genet (2010) 0.92
Can we rely on PET in the follow-up of advanced seminoma patients? Urol Int (2012) 0.87
Collaborating with the enemy: function of macrophages in the development of neoplastic disease. Mediators Inflamm (2013) 0.84
Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Leuk Lymphoma (2014) 0.81
Alendronate 70 therapy in elderly women with post-menopausal osteoporosis: the problem of compliance. Endokrynol Pol (2011) 0.81
Polish consensus statement on the protective stoma. Pol Przegl Chir (2014) 0.79
Benign mesocolon schwannoma in PET/CT and immunohistochemistry assessment: a case report. Contemp Oncol (Pozn) (2012) 0.77
Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes. PLoS One (2013) 0.75
Application of immunohistochemistry for detection of metastases in sentinel lymph nodes of non-advanced breast cancer patients. Pol J Pathol (2015) 0.75
[The importance of imaging techniques in the modern treatment of multiple myeloma]. Przegl Lek (2014) 0.75
Oxygenation of RZn(N,O)-type complexes as an efficient route to zinc alkoxides not accessible via the classical alcoholysis path. Chem Commun (Camb) (2017) 0.75
Problems concerning patients' qualification for surgical procedures allowing for evaluation of the condition of axillary fossa lymph nodes in the radical treatment of breast cancer. Pol Przegl Chir (2015) 0.75
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer]. Pol Merkur Lekarski (2004) 0.75
[Standardized surgical procedures for treating cancers of the colon, rectum and anus]. Pol J Pathol (2014) 0.75
Clinical significance of Van Nuys Prognostic Index as a qualification criterion to sentinel lymph node biopsy in patients diagnosed with ductal carcinoma in situ. Pol Przegl Chir (2015) 0.75
Prevalence of biological types of breast cancer and their influence on disease staging and therapeutic management - a single-center study. Pol J Pathol (2017) 0.75
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy. Acta Oncol (2013) 0.75
[Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia]. Pol Merkur Lekarski (2004) 0.75
[Skin cancer screening program in the population of Bydgoszcz]. Wiad Lek (2004) 0.75
Histopathological lesions in different types of skin aging. Acta Dermatovenerol Alp Pannonica Adriat (2010) 0.75
Activity of antioxidant enzymes in melanoma patients. Int J Dermatol (2013) 0.75